Stryker Co. (NYSE:SYK) Shares Acquired by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. lifted its position in shares of Stryker Co. (NYSE:SYK) by 6.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,222 shares of the medical technology company’s stock after acquiring an additional 130 shares during the quarter. Tocqueville Asset Management L.P.’s holdings in Stryker were worth $795,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in SYK. Dynamic Advisor Solutions LLC boosted its holdings in Stryker by 56.6% during the fourth quarter. Dynamic Advisor Solutions LLC now owns 2,945 shares of the medical technology company’s stock worth $870,000 after buying an additional 1,064 shares in the last quarter. Brookstone Capital Management boosted its holdings in Stryker by 2.2% during the fourth quarter. Brookstone Capital Management now owns 8,198 shares of the medical technology company’s stock worth $2,455,000 after buying an additional 176 shares in the last quarter. Cyndeo Wealth Partners LLC boosted its holdings in Stryker by 4.3% during the fourth quarter. Cyndeo Wealth Partners LLC now owns 1,079 shares of the medical technology company’s stock worth $323,000 after buying an additional 44 shares in the last quarter. LVM Capital Management Ltd. MI boosted its holdings in Stryker by 4.2% during the fourth quarter. LVM Capital Management Ltd. MI now owns 39,464 shares of the medical technology company’s stock worth $11,818,000 after buying an additional 1,578 shares in the last quarter. Finally, Fortitude Family Office LLC purchased a new stake in Stryker during the fourth quarter worth about $55,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

SYK has been the topic of a number of research analyst reports. Stifel Nicolaus boosted their price objective on shares of Stryker from $350.00 to $375.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st. The Goldman Sachs Group assumed coverage on shares of Stryker in a report on Thursday, May 30th. They issued a “neutral” rating and a $372.00 price target on the stock. TD Cowen upped their price target on shares of Stryker from $365.00 to $400.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Royal Bank of Canada upped their price target on shares of Stryker from $360.00 to $386.00 and gave the company an “outperform” rating in a report on Monday, April 15th. Finally, BTIG Research upped their price target on shares of Stryker from $369.00 to $372.00 and gave the company a “buy” rating in a report on Monday, July 15th. Four investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, Stryker has an average rating of “Moderate Buy” and a consensus target price of $372.05.

Stryker Trading Up 2.9 %

SYK stock traded up $9.72 on Friday, hitting $340.95. 2,421,857 shares of the company were exchanged, compared to its average volume of 967,140. Stryker Co. has a twelve month low of $249.98 and a twelve month high of $361.41. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. The business’s fifty day moving average is $338.30 and its two-hundred day moving average is $337.75. The stock has a market capitalization of $129.88 billion, a price-to-earnings ratio of 38.92, a price-to-earnings-growth ratio of 2.68 and a beta of 0.89.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, topping the consensus estimate of $2.36 by $0.14. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The firm had revenue of $5.24 billion during the quarter, compared to analyst estimates of $5.10 billion. During the same quarter in the prior year, the business posted $2.14 earnings per share. Stryker’s revenue for the quarter was up 9.7% compared to the same quarter last year. As a group, research analysts forecast that Stryker Co. will post 11.95 earnings per share for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be given a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a yield of 0.94%. The ex-dividend date of this dividend is Friday, June 28th. Stryker’s dividend payout ratio (DPR) is 36.53%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.